MedTrace Logo

Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior

NCT00663871 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 272

Last updated 2021-06-11

Study results available
· View outcomes & findings →

Summary

Omega-3 fatty acids are a certain kind of fish fat that has recently been shown to have health benefits. This study will examine the effectiveness of fish oil supplementation for reducing the early signs of heart disease risk and for improving mood, impulsivity, and anger levels.

Conditions

Interventions

DIETARY_SUPPLEMENT

Fish Oil

Participants will take 2 grams (1400 mg EPA and DHA) of fish oil supplements on a daily basis.

DIETARY_SUPPLEMENT

Soybean Oil (Placebo)

Participants will take 2 grams of soybean oil supplements on a daily basis.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • Office of Dietary Supplements (ODS)

    collaborator NIH

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Matthew F. Muldoon, MD, MPH · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00663871 on ClinicalTrials.gov